Pharmaceutical Value proposition
New ways to care
Laboratoires Pierre Fabre held by the Pierre Fabre Foundation, is a worldwide company with a unique positioning : the alliance of pharmaceutical and dermocosmetics expertise.
This makes Pierre Fabre Group :
đ A pharmaceutical group with a strong positioning : medical and natural
đ„ The second largest dermo-cosmetics laboratory in the world
đ„ The second largest private French pharmaceutical group
đ„ The market leader in France for products sold over the counter in pharmacies.
Our portfolio includes several medical franchises and international brands including ;
Pharmaceutical Care
Pierre Fabre Oncologie
Pierre Fabre Dermatologie
Naturactive
Eau Thermale AvĂšne
Klorane
Ducray
René Furterer
A-Derma
Pierre Fabre Oral Care
Glytone (US)
Darrow (Brasil)
Established in the Occitanie region since its creation, we manufacture over 95% of our products in France. We keep innovating passionately with our teams in 2 innovation centers in Brasil and Japan as well as in 6 R&D centers in France.
Thanks to our 9,600 employees in 44 subsidiaries and our distribution activities in 120 countries, our group generated âŹ2.7 billion in revenues in 2022, 69% of which is from international business.
Pierre Fabre Group has a unique company structure.
86% of the Pierre Fabre Group is held by the Pierre Fabre Foundation, a government-recognized public-interest foundation, while a smaller share is owned by its employees via an employee stock ownership plan.
In 2020, the independent organization ECOCERT Environment awarded Pierre Fabre's CSR policy at "excellence" level : - Excellence being the highest maturity level of the ECOCERT 26000 standard.
From Health to Beauty, Family Health, Dermo-Cosmetics, Pharmaceuticals, De la Santé à la Beauté, Dermo-Cosmétique, Médicaments, Santé Familiale, oncology, skincare, haircare, and personal careOriginal language
New Ways To Care
Laboratoires Pierre Fabre held by the Pierre Fabre Foundation, is a worldwide company with a unique positioning : the alliance of pharmaceutical and dermocosmetics expertise. This makes Pierre Fabre Group : đ A pharmaceutical group with a strong positioning : medical and natural đ„ The second largest dermo-cosmetics laboratory in the world đ„ The second largest private French pharmaceutical group đ„ The market leader in France for products sold over the counter in pharmacies. Our portfolio includes several medical franchises and international brands including ; Pharmaceutical Care Pierre Fabre Oncologie Pierre Fabre Dermatologie Naturactive Eau Thermale AvĂšne Klorane Ducray RenĂ© Furterer A-Derma Pierre Fabre Oral Care Glytone (US) Darrow (Brasil) Established in the Occitanie region since its creation, we manufacture over 95% of our products in France. We keep innovating passionately with our teams in 2 innovation centers in Brasil and Japan as well as in 6 R&D centers in France. Thanks to our 9,600 employees in 44 subsidiaries and our distribution activities in 120 countries, our group generated âŹ2.7 billion in revenues in 2022, 69% of which is from international business. Pierre Fabre Group has a unique company structure. 86% of the Pierre Fabre Group is held by the Pierre Fabre Foundation, a government-recognized public-interest foundation, while a smaller share is owned by its employees via an employee stock ownership plan. In 2020, the independent organization ECOCERT Environment awarded Pierre Fabre's CSR policy at "excellence" level : - Excellence being the highest maturity level of the ECOCERT 26000 standard.
Pierre Fabre | A French pharmaceutical and dermocosmetics group
Pierre Fabre | A French pharmaceutical and dermocosmetics group
https://www.pierre-fabre.com/en
| Entity | Type | Tweets | Articles | |
|---|---|---|---|---|
 | TEAM ONE GROUPE Events Services, traveltech | Other 8 Feb 2024 | | |
 | Institut Saint-Jacques healthtech | Other 31 Dec 2023 | | |
 | Inserm Toulouse healthtech | Other 17 Feb 2023 | | |
 | Panzi Hospital and Foundation healthtech | Other 9 Sep 2024 | | |
 | Fédération Française de la Peau biotech, deeptech, healthtech | Other 17 Jul 2022 | | |
 | Performance Directe fintech, martech, Advertising Services | Other 11 Jul 2024 | | |
 | Union Mutame healthtech, Wellness and Fitness Services | Other 4 Feb 2024 | | |
 | CHU de Rouen Hospitals and Health Care | Other 3 Feb 2024 | | |
 | Collective Thinking devient Ospi it services, healthtech, Software Development | Other 6 Feb 2024 | | |
 | Basel Area Business & Innovation International Trade and Development | Other 1 Feb 2024 | | |